amdinocillin pivoxil has been researched along with ciprofloxacin in 6 studies
| Studies (amdinocillin pivoxil) | Trials (amdinocillin pivoxil) | Recent Studies (post-2010) (amdinocillin pivoxil) | Studies (ciprofloxacin) | Trials (ciprofloxacin) | Recent Studies (post-2010) (ciprofloxacin) |
|---|---|---|---|---|---|
| 240 | 89 | 46 | 16,060 | 1,331 | 6,092 |
| Protein | Taxonomy | amdinocillin pivoxil (IC50) | ciprofloxacin (IC50) |
|---|---|---|---|
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | 0.41 | |
| DNA gyrase subunit B | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
| DNA gyrase subunit A | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.31 | |
| DNA gyrase subunit B | Staphylococcus aureus | 4.32 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 0.6845 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 0.5632 | |
| DNA topoisomerase 4 subunit B | Staphylococcus aureus | 6.485 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 4.8011 | |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.41 | |
| DNA gyrase subunit A | Staphylococcus aureus | 4.32 | |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.41 | |
| DNA topoisomerase 4 subunit A | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
| DNA topoisomerase 4 subunit B | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
| GABA theta subunit | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | 0.41 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Auer, S; Hell, M; Wojna, A | 1 |
| Claramonte, X; Jiménez de Anta, MT; Martos Rodríguez, A; Mensa, J; Moreno, A; Ribot, T; Sanfeliu, I; Segura Porta, F; Serrate, G | 1 |
| Bennish, ML; Dhar, U; Khan, WA; Salam, MA | 1 |
| Black, RE; Munos, M; Traa, BS; Walker, CL | 1 |
| Burström, B; Ericsson, O; Ljung, R; Reimers, A | 1 |
| Frimodt-Møller, N; Kahlmeter, G; Larsen, AR; Simonsen, GS | 1 |
1 review(s) available for amdinocillin pivoxil and ciprofloxacin
| Article | Year |
|---|---|
Antibiotics for the treatment of dysentery in children.
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Dysentery; Dysentery, Bacillary; Female; Humans; Infant; Male; Randomized Controlled Trials as Topic; Salmonella Infections; Shigella dysenteriae; Treatment Outcome | 2010 |
2 trial(s) available for amdinocillin pivoxil and ciprofloxacin
| Article | Year |
|---|---|
[Antibiotic treatment of acute gastroenteritis].
Topics: Acute Disease; Adolescent; Adult; Aged; Amdinocillin Pivoxil; Anti-Infective Agents; Ciprofloxacin; Gastroenteritis; Humans; Middle Aged; Penicillins; Salmonella; Salmonella Infections | 1997 |
Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
Topics: Adolescent; Amdinocillin Pivoxil; Anti-Infective Agents; Arthralgia; Child; Child, Preschool; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Dysentery, Bacillary; Feces; Follow-Up Studies; Hospitalization; Humans; Joint Diseases; Patient Discharge; Penicillin Resistance; Penicillins; Safety; Shigella; Suspensions; Tablets; Treatment Outcome | 1998 |
3 other study(ies) available for amdinocillin pivoxil and ciprofloxacin
| Article | Year |
|---|---|
Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Urinary Tract Infections | 2010 |
Inequality in quality? Regional and educational differences in treatment with fluoroquinolone in urinary tract infection of 236,376 Swedish patients.
Topics: Adolescent; Adult; Age Distribution; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Utilization; Female; Fluoroquinolones; Guideline Adherence; Healthcare Disparities; Humans; Middle Aged; Multivariate Analysis; Nitrofurantoin; Norfloxacin; Practice Patterns, Physicians'; Quality Indicators, Health Care; Risk Adjustment; Social Class; Sweden; Trimethoprim; Urinary Tract Infections | 2011 |
Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption.
Topics: Amdinocillin; Amdinocillin Pivoxil; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Humans; Urinary Tract Infections | 2022 |